Literature DB >> 19828707

Dual-energy X-ray absorptiometry modeling to explain the increased resting energy expenditure associated with the HIV lipoatrophy syndrome.

Lisa A Kosmiski1, Brandy M Ringham, Gary K Grunwald, Daniel H Bessesen.   

Abstract

BACKGROUND: The HIV lipoatrophy syndrome is characterized by loss of subcutaneous fat and is associated with increased resting energy expenditure (REE). Recently, dual-energy X-ray absorptiometry (DXA) modeling of organ-tissue mass combined with specific organ-tissue metabolic rates has been used to gain further insight into the relation of the lean body mass to REE and to better understand differences in REE between groups.
OBJECTIVE: This study examined the organ-tissue basis of the increased REE shown in HIV lipoatrophy.
DESIGN: REE was measured in 29 HIV-infected patients with lipoatrophy and in 29 HIV-infected and 19 healthy control subjects. Five organ-tissue mass components (brain, bone, skeletal muscle, adipose tissue, and residual mass) were calculated with the use of DXA modeling and body weight.
RESULTS: DXA modeling showed no significant differences in predicted REE between the 3 groups. However, measured REE was significantly greater in subjects with lipoatrophy than in control subjects. Measured REE remained significantly greater in lipoatrophy subjects after routine adjustment for lean body mass and after adjustment for each organ-tissue mass component. Finally, DXA and regression modeling of REE suggests that increased energy expenditure in skeletal muscle may account for the resting hypermetabolism of patients with HIV lipoatrophy.
CONCLUSIONS: Increased REE in subjects with HIV lipoatrophy cannot be explained by differences in organ-tissue mass as modeled by DXA. Instead, DXA and regression modeling of REE suggests that skeletal muscle is hypermetabolic in patients with HIV lipoatrophy. This may be a form of adaptive thermogenesis in response to an inability to store triglyceride fuel in a normal manner.

Entities:  

Mesh:

Year:  2009        PMID: 19828707      PMCID: PMC2777466          DOI: 10.3945/ajcn.2009.28103

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  33 in total

Review 1.  Recent advances in adaptive thermogenesis: potential implications for the treatment of obesity.

Authors:  S L J Wijers; W H M Saris; W D van Marken Lichtenbelt
Journal:  Obes Rev       Date:  2008-10-23       Impact factor: 9.213

2.  Increased substrate oxidation and mitochondrial uncoupling in skeletal muscle of endurance-trained individuals.

Authors:  Douglas E Befroy; Kitt Falk Petersen; Sylvie Dufour; Graeme F Mason; Douglas L Rothman; Gerald I Shulman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  Body-size dependence of resting energy expenditure can be attributed to nonenergetic homogeneity of fat-free mass.

Authors:  Steven B Heymsfield; Dympna Gallagher; Donald P Kotler; Zimian Wang; David B Allison; Stanley Heshka
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-01       Impact factor: 4.310

4.  Serum adiponectin and leptin levels in patients with lipodystrophies.

Authors:  Wasim A Haque; Iichiro Shimomura; Yuji Matsuzawa; Abhimanyu Garg
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

5.  Effect of triiodothyronine on mitochondrial energy coupling in human skeletal muscle.

Authors:  V Lebon; S Dufour; K F Petersen; J Ren; B M Jucker; L A Slezak; G W Cline; D L Rothman; G I Shulman
Journal:  J Clin Invest       Date:  2001-09       Impact factor: 14.808

6.  Leptin-replacement therapy for lipodystrophy.

Authors:  Elif Arioglu Oral; Vinaya Simha; Elaine Ruiz; Alexa Andewelt; Ahalya Premkumar; Peter Snell; Anthony J Wagner; Alex M DePaoli; Marc L Reitman; Simeon I Taylor; Phillip Gorden; Abhimanyu Garg
Journal:  N Engl J Med       Date:  2002-02-21       Impact factor: 91.245

7.  Syndrome of body fat redistribution in HIV-1-infected patients: relationships to cortisol and catecholamines.

Authors:  E Renard; J Fabre; F Paris; J Reynes; J Bringer
Journal:  Clin Endocrinol (Oxf)       Date:  1999-08       Impact factor: 3.478

8.  Peripheral administration of human corticotropin-releasing hormone: a novel method to increase energy expenditure and fat oxidation in man.

Authors:  S R Smith; L de Jonge; M Pellymounter; T Nguyen; R Harris; D York; S Redmann; J Rood; G A Bray
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

9.  Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.

Authors:  L A Kosmiski; D R Kuritzkes; K A Lichtenstein; D H Glueck; P J Gourley; E R Stamm; A L Scherzinger; R H Eckel
Journal:  AIDS       Date:  2001-10-19       Impact factor: 4.177

10.  No evidence of mass dependency of specific organ metabolic rate in healthy humans.

Authors:  Wiebke Later; Anja Bosy-Westphal; Britta Hitze; Elke Kossel; C-C Glüer; Martin Heller; Manfred J Müller
Journal:  Am J Clin Nutr       Date:  2008-10       Impact factor: 7.045

View more
  3 in total

1.  Effect of resistance training on resting metabolic rate and its estimation by a dual-energy X-ray absorptiometry metabolic map.

Authors:  J C Aristizabal; D J Freidenreich; B M Volk; B R Kupchak; C Saenz; C M Maresh; W J Kraemer; J S Volek
Journal:  Eur J Clin Nutr       Date:  2014-10-08       Impact factor: 4.016

2.  Cerebrospinal fluid metabolomics implicate bioenergetic adaptation as a neural mechanism regulating shifts in cognitive states of HIV-infected patients.

Authors:  Alex M Dickens; Daniel C Anthony; Reena Deutsch; Michelle M Mielke; Timothy D W Claridge; Igor Grant; Donald Franklin; Debra Rosario; Thomas Marcotte; Scott Letendre; Justin C McArthur; Norman J Haughey
Journal:  AIDS       Date:  2015-03-13       Impact factor: 4.177

3.  Self-reported body fat change in HIV-infected men is a marker of decline in physical health-related quality of life with aging, independent of co-morbidity.

Authors:  Kristine M Erlandson; Sandra M Reynolds; Christopher Cox; Frank J Palella; Mallory D Witt; Lawrence A Kingsley; Todd T Brown; Michael Plankey
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.